Form 4 · Filed Mar 4, 2026, 12:00 PM UTC
ALNY/ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne — Chief Executive Officer
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a Sonnet-4.6 (or Opus-4.7 on flagged buys) thesis attached.
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4 (Sonnet 4.6)
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moOpus 4.7 deep theses + SMS alerts + cluster-buy detection.
- · Everything in Pro
- · Opus-grade thesis on flagged buys
- · SMS alerts for highest-conviction filings
Transactions
13 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | A | other | 13,844 | $0 | $0 | 105,427 |
| Mar 2, 2026 | S | sell | 200 | $324 | $64,724 | 105,227 |
| Mar 2, 2026 | S | sell | 382 | $325 | $124,016 | 104,845 |
| Mar 2, 2026 | S | sell | 1,098 | $326 | $357,542 | 103,747 |
| Mar 2, 2026 | S | sell | 1,669 | $327 | $545,446 | 102,078 |
| Mar 2, 2026 | S | sell | 1,399 | $328 | $458,410 | 100,679 |
| Mar 2, 2026 | S | sell | 424 | $329 | $139,373 | 100,255 |
| Mar 2, 2026 | S | sell | 722 | $330 | $238,051 | 99,533 |
| Mar 2, 2026 | S | sell | 346 | $331 | $114,474 | 99,187 |
| Mar 2, 2026 | S | sell | 399 | $332 | $132,440 | 98,788 |
| Mar 2, 2026 | S | sell | 160 | $333 | $53,222 | 98,628 |
| Mar 2, 2026 | A | other | 30,425 | $0 | $0 | 30,425 |
| Mar 2, 2026 | A | other | 110,746 | $0 | $0 | 110,746 |
Source: SEC EDGAR raw filing ↗ · Accession 0001735276-26-000048